Find Dirocaftor manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Dirocaftor [usan], Pti-808, 2g3t6m1as9, Dirocaftor (usan), 2137932-23-9, 3-quinolinecarboxamide, 1,4-dihydro-n-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-
Molecular Formula
C22H28N2O3Si2
Molecular Weight
424.6  g/mol
InChI Key
TYQIFWXBQYAKCR-UHFFFAOYSA-N
FDA UNII
2G3T6M1AS9

Dirocaftor
Dirocaftor is under investigation in clinical trial NCT03251092 (Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis).
1 2D Structure

Dirocaftor

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[5-hydroxy-2,4-bis(trimethylsilyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide
2.1.2 InChI
InChI=1S/C22H28N2O3Si2/c1-28(2,3)19-12-20(29(4,5)6)18(25)11-17(19)24-22(27)15-13-23-16-10-8-7-9-14(16)21(15)26/h7-13,25H,1-6H3,(H,23,26)(H,24,27)
2.1.3 InChI Key
TYQIFWXBQYAKCR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C[Si](C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)[Si](C)(C)C
2.2 Other Identifiers
2.2.1 UNII
2G3T6M1AS9
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Dirocaftor [usan]

2. Pti-808

3. 2g3t6m1as9

4. Dirocaftor (usan)

5. 2137932-23-9

6. 3-quinolinecarboxamide, 1,4-dihydro-n-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-

7. N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

8. Dirocaftor [inn]

9. Unii-2g3t6m1as9

10. Chembl4594297

11. Who 11355

12. Hy-137437

13. Cs-0138638

14. D11781

15. N-[5-hydroxy-2,4-bis(trimethylsilyl)phenyl]-4-oxo-1h-quinoline-3-carboxamide

2.4 Create Date
2019-12-06
3 Chemical and Physical Properties
Molecular Weight 424.6 g/mol
Molecular Formula C22H28N2O3Si2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass424.16384583 g/mol
Monoisotopic Mass424.16384583 g/mol
Topological Polar Surface Area78.4 Ų
Heavy Atom Count29
Formal Charge0
Complexity681
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty